Drug Summary
Drug name: doxazosin Chemical name: Doxazosin mesylate Formula: C23H25N5O5 Weight: 451.4751 CAS no: 74191-85-8 DrugBank link: DB00590 Description: Doxazosin is a quinazoline-derivative that selectively antagonizes postsynaptic α1-adrenergic receptors. It may be used to mild to moderate hypertension and in the management of symptomatic benign prostatic hyperplasia (BPH). α1-Receptors mediate contraction and hypertrophic growth of smooth muscle cells. Antagonism of these receptors leads to smooth muscle relaxation in the peripheral vasculature and prostate gland. Indication: For treatment and management of mild to moderate hypertension and urinary obstruction symptoms caused by BPH.